Cutting Edge Haematology: Response and Resistance to Targeted Therapies

Symposium

Cutting Edge Haematology: Response and Resistance to Targeted Therapies

Davis Auditorium
Walter and Eliza Hall Institute

Parkville

1G Royal Parade

Booking not required

This symposium will showcase local studies that are identifying and measuring response and resistance to new targeted therapies in haematology.

The program will include:

  • An introduction to targeted therapies in the clinic
  • Concepts and approaches in treating resistance and preventing recurrence
  • An in-depth look at targets, current trials and opportunities for development in acute and chronic leukemias, lymphoma and myeloma.

Keynote address from Professor Mark Dawson, Head of the Translational Haematology Program, Group leader of the Cancer Epigenetics Laboratory and Consultant Haematologist in the Department of Haematology, Peter MacCallum Cancer Centre.

Chaired by Professor Andrew Roberts, VCCC Haematology Lead in Research and Education, Metcalf Chair of Leukaemia Research at the University of Melbourne, and Head of Clinical Translation at the Walter and Eliza Hall Institute.

All Symposia